Varian Medical Systems has been selected through its distributor, Business Alignment, to supply and install a ...Read more
Sartorius Stedim Biotech (SSB) recently announced an agreement with Nova Biomedical (Nova), a well-known US ma...Read more
Drugs: Approved, and seeking approval
In 2016, the US Food and Drug Administration (FDA) approved 22 new drugs which was way lower than 2015 when 45 new drugs were launched. It was a year of disappointment for pharmaceutical companies and drug developers. However, the industry is optimistic that research on novel drugs has not slowed down and wheels of innovation is spinning ahead. BioSpectrum Asia takes a look at the drugs that are in phase III of clinical trial or have been recently approved. These drugs are indicated for life-
threatening diseases and once available in the market, they would be effective in battling the disease burden.